Answers are grounded in this paper and cite their sources.
The first international guideline on treatment and management of long-chain fatty acid oxidation disorders has been published and demonstrates little scientific evidence for many of the treatment decisions. However, it is a substantial achievement to harmonize treatment and to define the remaining challenges. We here deliver some thoughts on this guideline and highlight the tremendous effort to reach this international consensus.
No takes yet. Share an insight, caveat, or question.
Spiekerkoetter et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: